Compare FORM & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FORM | TFX |
|---|---|---|
| Founded | 1993 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.8B |
| IPO Year | 2002 | 1994 |
| Metric | FORM | TFX |
|---|---|---|
| Price | $149.09 | $126.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $98.25 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.4M | 536.3K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $19.43 | $15.97 |
| Revenue Next Year | $7.31 | $5.15 |
| P/E Ratio | $576.27 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.00 | $100.18 |
| 52 Week High | $159.09 | $139.67 |
| Indicator | FORM | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 60.36 | 46.17 |
| Support Level | $113.14 | $124.49 |
| Resistance Level | $158.36 | $135.21 |
| Average True Range (ATR) | 10.21 | 3.76 |
| MACD | 2.73 | -0.70 |
| Stochastic Oscillator | 87.42 | 23.49 |
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.